Summary

How VLRX maps according to Revere

Sector Level Count
Industries 1
Sectors 2
Subsectors 6
Product/Service Groups 9

Specific product example for VLRX

Product Hierarchy
*Healthcare
Biopharmaceuticals
Endocrinology/Metabolism
Phase I/Phase II Clinical Stage Products

Company Highlights:

Market Cap. 130.850
Current Shares Outstnd. 14.9
Contact Name Stuart Z. Levine
Contact Phone (609)2353000
City, State Cranbury, NJ
Dividends Per Common Share 0.00
Dividend Yield n/a
SI %SHOUT 0.89
IH % Shares Outst. 20.82%
Number of Employees 101
Revenue Per Employee 128,391.8
Book Value Per Share 1.72
5 Year CAGR in Revenues % n/a
5 Year CAGR in Earnings % n/a
Asset Turnover 0.1
Fiscal Year End 12/31/2007
Next Reporting Period Mar, 2007

Business Description:

Valera Pharmaceuticals, Inc. (Valera) is a specialty pharmaceutical company concentrating on the development, acquisition and commercialization of products for the treatment of urological and endocrine conditions, diseases and disorders, including products that use its drug delivery technology. The Company?s first product, Vantas, was approved by the United States Food and Drug Administration (FDA) in October 2004. Other product candidates include Supprelin-LA, VP003 (Octreotide), VP004 (Naltrexone), VP005 (Anti-inflammatory), VP006 (rapid dissolve desmopressin), Valstar (Valrubicin) and Endoureteral Stent.

Chart:

Last Price 8.76
Price Chg. 0.00
Price Chg. % 0.00%
Open Price 8.74
High Price 8.89
Low Price 8.62
52w High Price 10.25
52w Low Price 4.49
Volume 81,748
30d Avg. Volume 25,816
VLRX - Chart
* Quotes delayed 20 minutes.

Competitors by Products

Products Manufactured/Services Performed/Product Name(s) - Competitors (Tickers)/Product Name(s):
*Healthcare
Biopharmaceuticals
Endocrinology/Metabolism
Phase I/Phase II Clinical Stage Products

Products:

  • VP003 (Octreotide)

Abbott Laboratories (ABT) Products:

  • Crestor (Rosuvastatin Calcium)/ABT-335 Combination Therapy
  • KOS Pharmaceuticals KI 02-212 (Inhaled Insulin)
  • KOS Pharmaceuticals KS 01-017

AEterna Zentaris Inc. (USA) (AEZS) Products:

  • Zentaris EP-1572 (Growth Hormone Secretagogue)

Akzo Nobel N.V. (ADR) (AKZOY) Products:

  • Andriol Testocaps
  • Org 3236 + TU

Alteon Inc. (ALT) Products:

  • Alagebrium Chloride
  • Pimagedine (Aminoguanidine)

Altus Pharmaceuticals Inc. (ALTU) Products:

  • ALTU-238 (Human Growth Hormone)
  • ALTU-242

Amgen, Inc. (AMGN) Products:

  • AMG 221
  • Sensipar (Cinacalcet Hydrochloride)

Amylin Pharmaceuticals, Inc. (AMLN) Products:

  • Nasal Exenatide (Incretin Mimetic)

Aradigm Corporation (ARDM) Products:

  • AERx Testosterone

Arena Pharmaceuticals, Inc. (ARNA) Products:

  • APD668 (Glucose-Dependent Insulinotropic Receptor Agonist)

AstraZeneca plc (ADR) (AZN) Products:

  • AZD1175
  • AZD2207
  • AZD2479 (Reverse Cholesterol Transport Enhancer)
  • AZD6610 (PPAR Alpha/Gamma Modulator)
  • Crestor (Rosuvastatin Calcium)/ABT-335 Combination Therapy
  • Dapagliflozin (DPP-4 Inhibitor)

AVANIR Pharmaceuticals (AVNR) Products:

  • AVP-26452

AVANT Immunotherapeutics, Inc. (AVAN) Products:

  • Cholesteryl Ester Transfer Protein Vaccine (CETi-1)

Bayer AG (ADR) (BAY) Products:

  • BAY 74-4113 (DGAT-1 Inhibitors)

Bentley Pharmaceuticals, Inc. (BNT) Products:

  • Intranasal Insulin

BioSante Pharmaceuticals, Inc. (BPA) Products:

  • Bio-E/P-Gel (Estradiol/ Progestogen Gel)

Bristol Myers Squibb Co. (BMY) Products:

  • Dapagliflozin (DPP-4 Inhibitor)
  • Next-Generation Statin
  • PPAR Agonist
  • QDose Inhaled Insulin
  • SGLT2 Inhibitor

CardioVascular BioTherapeutics, Inc. (CVBT) Products:

  • Cardio Vascu-Grow (Fibroblast Growth Factor-1)

Columbia Laboratories Inc. (CBRX) Products:

  • Lidocaine Vaginal Gel
  • Testosterone Progressive Hydration Vaginal Tablet

Corautus Genetics Inc. (VEGF) Products:

  • Vascular Endothelial Growth Factor 2 (VEGF-2) Gene Therapy

DepoMed, Inc. (DEPO) Products:

  • Gabapentin GR

DOV Pharmaceutical, Inc. (DOVP) Products:

  • Bicifadine

Dr. Reddy's Laboratories Limited (ADR) (RDY) Products:

  • DRF 11605
  • DRF-10945
  • DRF-NNPC (Insulin Sensitizer)

Eli Lilly & Co. (LLY) Products:

  • AI-401
  • AIR hGH (Inhaled Human Growth Hormone)
  • LY519818 (PPAR Agonist)
  • LY674
  • LY929 (PPAR Modulator)
  • Naveglitazar (LY519818)
  • PPAR Alpha Agonist
  • PPAR Modulator
  • PSN105/PSN010 (Glucokinase Activators)
  • TS-021 (DPP-IV Inhibitor)

Emisphere Technologies, Inc. (EMIS) Products:

  • Oral Glucagon-Like Peptides (GLPs)
  • Oral Insulin
  • Oral Recombinant Human Growth Hormone (rhGH)

EpiCept Corporation (EPCT) Products:

  • EpiCept NP-1 (Amitriptyline/Ketamine)

Exelixis, Inc. (EXEL) Products:

  • XL784

Flamel Technologies S.A. (ADR) (FLML) Products:

  • MEDUSA Basulin (Insulin)
  • MICROPUMP Metformin XL

Forbes Medi-Tech Inc. (USA) (FMTI) Products:

  • FM-VP4 (Phytostanol Analogue)

Genentech, Inc. (DNA) Products:

  • ALTU-238 (Human Growth Hormone)
  • Topical VEGF

Generex Biotechnology Corporation (GNBT) Products:

  • Buccal Metformin
  • Oral-lyn (Oral Insulin)

Genzyme Corporation (GENZ) Products:

  • Acid Sphingomyelinase Enzyme Replacement Therapy
  • Gene Therapy
  • GENZ-112638
  • Thymoglobulin (Anti-Thymocyte Globulin)
  • Thyrogen (Thyrotropin Alfa)

GlaxoSmithKline plc (ADR) (GSK) Products:

  • 189075 (Sodium Dependent Glucose Transport (SGLT-2) Inhibitor)
  • 232802 (Selective Estrogen Receptor Modulator)
  • 256073
  • 501516
  • 590735
  • 625019
  • 677954 (Dual PPAR Agonist)
  • Albugon/GSK716155 (Albumin-Glucagon)
  • Denagliptin
  • Solabegron

Human Genome Sciences (HGSI) Products:

  • GSK716155 (Albumin-Glucagon)

Incyte Corporation (INCY) Products:

  • INCB13739 (11-beta Hydroxysteroid Dehydrogenase)
  • INCB3284 (CCR2 Antagonist)

Insmed Incorporated (INSM) Products:

  • iPlex (Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin Like Growth Factor Binding Protein-3)

InterMune, Inc. (ITMN) Products:

  • Pirfenidone

ISIS Pharmaceuticals, Inc. (ISIS) Products:

  • ISIS 113715 (PTP-1B Antisense Inhibitor)
  • ISIS 301012 Oral (ApoB-100 Antisense Inhibitor)
  • ISIS 301012 Parenteral (ApoB-100 Antisense Inhibitor)

ISTA Pharmaceuticals, Inc. (ISTA) Products:

  • Vitrase (Hyaluronidase)

Johnson & Johnson (JNJ) Products:

  • APD668 (Glucose-Dependent Insulinotropic Receptor Agonist)
  • Metaglidasen
  • Scios GLP-1/Insulinotropin

King Pharmaceuticals, Inc. (KG) Products:

  • MRE0094 (Adenosine A2a Receptor Agonist)

Large Scale Biology Corp. (LSBC) Products:

  • Alpha Galactosidase A

Ligand Pharmaceuticals Inc. (LGND) Products:

  • GW 516 (PPAR Modulator)
  • LGD 2941 (Androgen Agonist)
  • LY 674 (PPAR Agonist)
  • LY 929 (PPAR Modulator)
  • Naveglitazar (LY818)

Merck & Co., Inc. (MRK) Products:

  • MK-0533
  • MK-0677
  • MK-0867
  • MK-0893
  • MK-0941
  • MK-0974
  • MK-1642
  • MK-3887
  • Zetia (Ezetimibe)/Atorvastatin Combination Product

Merck Serono S.A. (ADR) (SRA) Products:

  • PTP 1b Inhibitor

Metabasis Therapeutics, Inc. (MBRX) Products:

  • CS-917 (Oral Gluconeogenesis Inhibitor)
  • MB07803 (Gluconeogenesis Inhibitor)
  • MB07811

Nastech Pharmaceutical (NSTK) Products:

  • Rapid-Acting Intranasal Insulin

Nektar Therapeutics (NKTR) Products:

  • AeroDose Insulin
  • Macugen (Pegaptanib Sodium)

New River Pharmaceuticals, Inc. (NRPH) Products:

  • NRP409 (Triiodothyronine Hormone )

Novartis AG (ADR) (NVS) Products:

  • LBM642 (PPAR Agonist)
  • SOM230 (Pasireotide)

Novavax, Inc. (NVAX) Products:

  • Androsorb (Transdermal Testosterone)

Noven Pharmaceuticals, Inc. (NOVN) Products:

  • Transdermal Testosterone Patch

Novo Nordisk A/S (ADR) (NVO) Products:

  • NN 344 (Long-Acting Insulin Analog)
  • NN5401

NPS Pharmaceuticals, Inc. (NPSP) Products:

  • Preos (Human Parathyroid Hormone)
  • Sensipar (Cinacalcet Hydrochloride)

OrthoLogic Corporation (OLGC) Products:

  • Chrysalin (Thrombin Derivative)

OSI Pharmaceuticals, Inc. (OSIP) Products:

  • PSN010 (Glucokinase Activators)
  • PSN357 (Glycogen Phosphlorylase Inhibitor)
  • PSN9301 (Dipeptidyl Peptidase-IV Inhibitor)

Pfizer Inc. (PFE) Products:

  • BAY 74-4113 (DGAT-1 Inhibitors)
  • PD-299685
  • PF-734200
  • PF-915275
  • PH-794428

Pharmacopeia Drug Discovery, Inc. (PCOP) Products:

  • PS522501

Protalix BioTherapeutics Inc. (PLX) Products:

  • prGCD (Recombinant Glucocerebrosidase)

QLT Inc. (USA) (QLTI) Products:

  • Atrigel Ocreotide

Regeneron Pharmaceuticals, Inc. (REGN) Products:

  • Interleukin-1 Cytokine Trap (Rilonacept)

Roche Holding Ltd. (ADR) (RHHBY) Products:

  • BIM 51077 (GLP-1 Analogue)
  • R1438 (Enzyme Inhibitor)
  • R1439 (Nuclear Receptor Modulator)
  • R1440 (Enzyme Modulator)
  • R1658 (Cholesteryl Ester Transfer Protein (CETP) Inhibitor)

Sangamo Biosciences, Inc. (SGMO) Products:

  • SB-509 (Zinc Finger DNA-Binding Proteins)

sanofi-aventis (ADR) (SNY) Products:

  • AVE-0010 (Glucagons-Like Peptide-1 Receptor Agonist)
  • AVE-7688 (Ilepatril)
  • AVE0847 (PPAR Agonist)
  • AVE0897 (PPAR Agonist)
  • AVE1625 (CB1 Receptor Antagonist)
  • AVE2268 (SGLT2 Inhibitor)
  • AVE5530 (Cholesterol Absorption Inhibitor)
  • AVE8134 (PPAR-Alpha Agonist)

Schering-Plough Corporation (SGP) Products:

  • PS522501
  • Zetia (Ezetimibe)/Atorvastatin Combination Product

Sciele Pharma Inc. (SCRX) Products:

  • Fenofibrate/Pravastatin

SkyePharma PLC (ADR) (SKYE) Products:

  • HgH (Human Growth Hormone)

Solvay S.A. (ADR) (SVYSY) Products:

  • Solvay Pharmaceuticals Combined Estrogen And Progestogen Gel
  • Unimed Pharmaceuticals Androgel (Testosterone Gel)

Spherix Incorporated (SPEX) Products:

  • BioSpherix Naturlose (Tagatose)

SuperGen, Inc. (SUPG) Products:

  • Pyrazinolyguanidine

Tercica, Inc. (TRCA) Products:

  • Increlex (Mecasermin)
  • Somatuline Autogel

The Quigley Corporation (QGLY) Products:

  • Quigley Pharma QR-333

Titan Pharmaceuticals, Inc. (TTP) Products:

  • DITPA

Tyco International Ltd. (TYC) Products:

  • Mallinckrodt Octreotide PR

Wyeth (WYE) Products:

  • PPM-204

XTL Biopharmaceuticals Ltd. (ADR) (XTLB) Products:

  • Bicifadine
Reproductive Disorders
Abnormal Puberty
Precocious
Gonadotropin Releasing Hormone (GnRH) Agonists

Products:

  • Supprelin-LA (Histrelin)

Abbott Laboratories (ABT) Products:

  • Lupron/Lupron Depot Series (Leuprolide Acetate)

Novartis AG (ADR) (NVS) Products:

  • Eon Labs Leuprolide Acetate

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Products:

  • IVAX Leuprolide
  • Sicor Leuprolide Acetate
Obstetrics/Gynecology
Female Genital Disorders
Ovarian
Abnormal Puberty
Precocious
Gonadotropin Releasing Hormone (GnRH) Agonists

Products:

  • Supprelin-LA (Histrelin)

Abbott Laboratories (ABT) Products:

  • Lupron/Lupron Depot Series (Leuprolide Acetate)

Novartis AG (ADR) (NVS) Products:

  • Eon Labs Leuprolide Acetate

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Products:

  • IVAX Leuprolide
  • Sicor Leuprolide Acetate
Oncology
Urology
Prostate Cancer
Palliative Agents
Gonadotropin Releasing Hormone (GnRH) Agonists

Products:

  • Vantas (Histrelin)

Abbott Laboratories (ABT) Products:

  • Lupron/Lupron Depot Series (Leuprolide Acetate)

AstraZeneca plc (ADR) (AZN) Products:

  • Zoladex 1-Month Depot (Goserelin Acetate Implant)
  • Zoladex 3-Month Depot (Goserelin Acetate Implant)

Bayer AG (ADR) (BAY) Products:

  • Viadur (Leuprolide Acetate)

Johnson & Johnson (JNJ) Products:

  • Viadur (Leuprolide Acetate Implant)

Novartis AG (ADR) (NVS) Products:

  • Eon Labs Leuprolide Acetate

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Products:

  • IVAX Leuprolide
  • Sicor Leuprolide Acetate
Urinary Bladder Cancer
Transitional Cell Carcinoma
Topoisomerase II Inhibitors

Products:

  • Valstar (Valrubicin)

Bristol Myers Squibb Co. (BMY) Products:

  • Rubex (Doxorubicin Hydrochloride)

Pfizer Inc. (PFE) Products:

  • Adriamycin (Doxorubicin Hydrochloride)

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Products:

  • Sicor Doxorubicin HCl
Toxicology
Phase I/Phase II Clinical Stage Products

Products:

  • VP004 (Naltrexone)

Alkermes, Inc. (ALKS) Products:

  • ALKS 29

AVI BioPharma, Inc. (AVII) Products:

  • AVI-4557

Baxter International Inc. (BAX) Products:

  • BioScavenger (Plasma-Derived Butyrylcholinesterase)

Catalyst Pharmaceutical Partners, Inc. (CPRX) Products:

  • CPP-109 (Vigabatrin)

Computer Sciences Corporation (CSC) Products:

  • BioScavenger (Plasma-Derived Butyrylcholinesterase)

DOV Pharmaceutical, Inc. (DOVP) Products:

  • DOV 102,677
  • DOV 216,303

Genzyme Corporation (GENZ) Products:

  • Iron Chelator (Hydroxybenzylethylenediaminediacetic Acid)

GlaxoSmithKline plc (ADR) (GSK) Products:

  • 468816 (Glycine Receptor Antagonist)

Nabi Biopharmaceuticals (NABI) Products:

  • NicVax (Nicotine Conjugate Vaccine)

Novartis AG (ADR) (NVS) Products:

  • Exjade (Deferasirox)

sanofi-aventis (ADR) (SNY) Products:

  • SR 14778 (Surinabant)

Somaxon Pharmaceuticals, Inc. (SOMX) Products:

  • Nalmefene
Urology
Phase I/Phase II Clinical Stage Products

Products:

  • VP006 (Desmopressin Modified Release)

Abraxis BioScience, Inc. (ABBI) Products:

  • Abraxane (Paclitaxel Protein-Bound Particles For Injectable Suspension)

AEterna Zentaris Inc. (USA) (AEZS) Products:

  • Zentaris Ozarelix/D-63153 (LHRH Antagonist)
  • Zentaris Teverelix (LHRH Antagonist)

Affymax, Inc. (AFFY) Products:

  • Hematide (Erythropoiesis-Stimulating Agent)

Alexion Pharmaceuticals, Inc. (ALXN) Products:

  • Soliris (Eculizumab)

Allergan, Inc. (AGN) Products:

  • Botox (Botulinum Toxin Type A)

Alteon Inc. (ALT) Products:

  • Alagebrium Chloride
  • Pimagedine (Aminoguanidine)

Amgen, Inc. (AMGN) Products:

  • Sensipar (Cinacalcet Hydrochloride)

Antares Pharma, Inc. (AIS) Products:

  • Anturol (Oxybutynin Advanced Transdermal Gel System)

AstraZeneca plc (ADR) (AZN) Products:

  • AZD7371

Auxilium Pharmaceuticals, Inc. (AUXL) Products:

  • AA4010 (Oxybutynin)
  • Injectable Collagenase ABC/AA4500

AVI BioPharma, Inc. (AVII) Products:

  • NEUGENE Antisense Drug/AVI-4126

Barr Pharmaceuticals, Inc. (BRL) Products:

  • Oxybutynin TVR

Bayer AG (ADR) (BAY) Products:

  • Berlex Oxybutynin Releasing Vaginal Ring
  • Schering Progestogen Etonogestrel

BioSpecifics Technologies Corp. (BSTC) Products:

  • Injectable Collagenase ABC/AA450

CuraGen Corporation (CRGN) Products:

  • CR002 (Anti-Platelet-Derived Growth Factor (PDGF) Antibody)

Eli Lilly & Co. (LLY) Products:

  • ICOS Tadalafil (PDE5 Selective Inhibitor)
  • Tadalafil

Exelixis, Inc. (EXEL) Products:

  • XL784

GlaxoSmithKline plc (ADR) (GSK) Products:

  • 366074 (Potassium Channel Opener)
  • Casopitant (NK-1 Receptor Antagonist)
  • Dutasteride/Testosterone
  • Solabegron

Indevus Pharmaceuticals (IDEV) Products:

  • IP 751 (Tetrahydrocannabinol Derivative)
  • Pagoclone (Gamma Amino Butyric Acid (GABA) Selective Receptor Modulator)

Keryx Biopharmaceuticals (KERX) Products:

  • Zerenex

King Pharmaceuticals, Inc. (KG) Products:

  • Bremelanotide/PT-141 (Alpha Melanocyte-Stimulating Hormone Analog)

Ligand Pharmaceuticals Inc. (LGND) Products:

  • LGD 2941 (Androgen Agonist)

Medarex, Inc. (MEDX) Products:

  • FG-3019 (Anti-CTGF Antibody)

MediciNova, Inc. (MNOV) Products:

  • MN-001
  • MN-246 (B3-Adrenergic Receptor Agonist)

Merck & Co., Inc. (MRK) Products:

  • MK-0594
  • MK-0634
  • NGD-8243/MK-2295 (Vanilloid Receptor-1 Modulator)

Nastech Pharmaceutical (NSTK) Products:

  • Apomorphine Hydrochloride

Neurocrine Biosciences, Inc. (NBIX) Products:

  • NBI-56418 (GnRH Antagonist)

Neurogen Corporation (NRGN) Products:

  • NGD-8243/MK-2295 (Vanilloid Receptor-1 Modulator)

Novartis AG (ADR) (NVS) Products:

  • SBR759 (Polynuclear Iron Starch/Saccharose Complex)

Novo Nordisk A/S (ADR) (NVO) Products:

  • Norditropin (r-Somatropin)

NPS Pharmaceuticals, Inc. (NPSP) Products:

  • Sensipar (Cinacalcet Hydrochloride)

Nymox Pharmaceutical Corporation (NYMX) Products:

  • NX-1207

Palatin Technologies, Inc. (PTN) Products:

  • Bremelanotide/PT-141 (Alpha Melanocyte-Stimulating Hormone Analog)

Pfizer Inc. (PFE) Products:

  • PF-3274167
  • PF-446687
  • S,S-Reboxetine
  • UK-369003

Repros Therapeutics Inc. (RPRX) Products:

  • Bimexes (Phentolamine-Based Small Molecule)
  • ERxin (Phentolamine-Based Small Molecule)

Roche Holding Ltd. (ADR) (RHHBY) Products:

  • R1484 (GPCR Modulator)
  • R450 (GPCR Modulator)
  • R701 (GPCR Antagonist)

sanofi-aventis (ADR) (SNY) Products:

  • AVE-7688 (Ilepatril)
  • SSR 240600 (NK1 Antagonist)

Schering-Plough Corporation (SGP) Products:

  • PDE 5 Inhibitor

Schwarz Pharma, Inc. (SWTZY) Products:

  • SPM969 (Pamirosin)

Solvay S.A. (ADR) (SVYSY) Products:

  • Solvay Pharmaceuticals SLV320
  • Unimed Pharmaceuticals Androgel (Testosterone Gel)

Spectrum Pharmaceuticals, Inc. (SPPI) Products:

  • Ozarelix (SPI-153)

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Products:

  • IVAX Uroflux

VIVUS, Inc. (VVUS) Products:

  • Avanafil (PDE5 Inhibitor)

Watson Pharmaceuticals, Inc. (WPI) Products:

  • Uracyst
Research/Preclinical Stage Products

Products:

  • VP005 (Anti-Inflammatory)

AEterna Zentaris Inc. (USA) (AEZS) Products:

  • ZEN-019 (LHRH Antagonist)
  • Zentaris LHRH Peptidomimetic

Alexion Pharmaceuticals, Inc. (ALXN) Products:

  • Anti-C5 Monoclonal Antibody Therapy

Altair Nanotechnologies, Inc. (ALTI) Products:

  • RenaZorb

Altus Pharmaceuticals Inc. (ALTU) Products:

  • ALTU-237 (Oxalate-Degrading Enzyme)

Auxilium Pharmaceuticals, Inc. (AUXL) Products:

  • Transmucosal Film Delivery System Compounds

Bentley Pharmaceuticals, Inc. (BNT) Products:

  • Topical Hormonal Therapy

Compugen Ltd. (USA) (CGEN) Products:

  • CGEN-34

Curis, Inc. (CRIS) Products:

  • BMP-7 Protein Program

Cyclacel Pharmaceuticals Inc. (CYCC) Products:

  • Cyclin Dependent Kinase Inhibitors

Flamel Technologies S.A. (ADR) (FLML) Products:

  • MEDUSA EPO XL (Erythropoietins)

Genzyme Corporation (GENZ) Products:

  • Anti-TGF beta
  • Second-Generation Sevelamer
  • Small Molecule Compound

GTx, Inc. (GTXI) Products:

  • Prostarine (Selective Androgen Receptor Modulator (SARM))

Keryx Biopharmaceuticals (KERX) Products:

  • Sulonex/KRX-101 (Sulodexide)

Ligand Pharmaceuticals Inc. (LGND) Products:

  • LGD-3303 (Selective Androgen Receptor Modulators (SARM))

Neurocrine Biosciences, Inc. (NBIX) Products:

  • Selective Norepinephrine Reuptake Inhibitor (SNRI) Compound

NexMed, Inc. (NEXM) Products:

  • NM100061 Early Ejaculation Cream

NitroMed, Inc. (NTMD) Products:

  • Nitric Oxide-Enhancing Arginines
  • Nitric-Oxide Enhancing PDE Inhibitors
  • NMI-3377

QLT Inc. (USA) (QLTI) Products:

  • Eligard Low Dose (Leuprolide Acetate)

Roche Holding Ltd. (ADR) (RHHBY) Products:

  • R1437 (GPCR Antagonist)
  • R1554 (GPCR Antagonist)
  • R873 (GPCR Agonist)

Shire plc (ADR) (SHPGY) Products:

  • SPD500

Spectrum Pharmaceuticals, Inc. (SPPI) Products:

  • RenaZorb

Unigene Laboratories (UGNE) Products:

  • Desmopressin
Medical Devices
Urology
Surgical
General Procedure
Minimally Invasive/Cystoscopy
Dilation
Stents
Ureteral

Products:

  • Ureteral Stent

Boston Scientific Corp. (BSX) Products:

  • Microvasive Contour Close Soft Percuflex Closed End Stent
  • Microvasive Contour VL Percuflex Stent
  • Microvasive Contour/Contour Injection Soft Percuflex Stent
  • Microvasive Fader Tip Series
  • Microvasive Mardis Series
  • Microvasive Percuflex Tail Plus Tapered Ureteral Stent
  • Microvasive Percuflex Urinary Diversion Series
  • Microvasive Percutaneous Combination Stent/Nephrostomy
  • Microvasive Speed Lok Soft Series
  • Microvasive Stamey Open Tip Series
  • Microvasive Stretch VL Variable Length Flexima Series
  • Microvasive Urinary Diversion Soft Series

C.R. Bard, Inc. (BCR) Products:

  • Double Pigtail
  • Double Pigtail Series
  • Fluoro-4 Series
  • Lubristent Series
  • Memotherm Urological Stent
  • Multi-Length Series
  • Silicone Figure Four Series
  • Urosoft/Puroflex Ureteral Stents

Teleflex Incorporated (TFX) Products:

  • Rusch Superglide
  • Rusch Superglide DD Tumour
  • Rusch Ureteral Stent Series

Key Financials

FY Ends December
Period Length/End 3 months
ending
12/31/2006 		3 months
ending
09/30/2006 		3 months
ending
12/31/2005 		12 months
ending
12/31/2006 		12 months
ending
12/31/2005 		12 months
ending
12/31/2004
Total Revenue 3.2 3.0 5.2 18.0 26.8 5.6
Gross Margin % 65.32 70.69 77.13 71.57 77.77 89.23
Operating Income -4.8 -5.0 -1.4 -15.1 -1.3 -12.3
Operating Margin % -149.52 -165.58 -27.47 -83.98 -4.91 -217.14
Tax Rate % 4.16 0.76 -5.29 1.46 -5.91 1.98
Income After Taxes -4.4 -4.7 -1.5 -13.9 -1.3 -12.0
Net Income Margin % -137.49 -155.46 -28.84 -77.59 -5.01 -212.95
F.D. EPS - Incl. Xord. Items -0.29 -0.31 -0.10 -1.03 -0.09 -1.22
Book Value Per Share 1.72 2.00 -2.15 1.72 -2.15 -2.03

Ratios

P/R Ratio (TTM) 7.28
P/E Ratio (TTM) n/a
Price To Free Cash Flow (TTM) -7.09
Price To Book Value 5.09
Net Assets to Market Cap. % 24.03%
Beta n/a
Days to Sell Inventory 484.6
Current Ratio 3.97
Quick Ratio 2.83
Interest Coverage n/a
Debt to Market Cap. % 0.01%
Return on Equity % -54.17
Return on Assets % -43.61
Return on Invested Capital % -57.73

Business/Geographical Segments